Clinical trial
Safety of Exposure to Natalizumab During Pregnancy
NCT05209815 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Exposure to Natalizumab During Pregnancy
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 20, 2022
- Completion date
- December 22, 2023
- Enrollment
- 68 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.